eHealth, Inc. (EHTH) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
EHTH currently has 30M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 4.48% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jan 06, 2026 |
8-K filing: eHealth, Inc. amended its H.I.G. Investment Agreement and Certificate of Designations related to its Series A preferred stock and its subsidiary, eHealthInsurance Services, Inc., entered into a new revolving credit agreement for $125.0 million. ($225.0M proceeds) |
30M | 0 |
| Aug 07, 2025 |
S-3 filing: This is an S-3 filing to register common stock, preferred stock, debt securities, depositary shares, warrants to purchase common stock, preferred stock, debt securities or depositary shares of the registrant, subscription rights to purchase common stock, preferred stock, debt securities, depositary shares, warrants or units consisting of some or all of these securities of the registrant, purchase contracts and units consisting of some or all of these securities, as may be sold from time to time by the registrant. $300,000,000 of unsold securities from a prior registration are being carried forward. |
30M | 0 |
| Aug 07, 2025 |
10-Q filing | 30.4M shares outstanding |
30M | 0 |
| May 07, 2025 |
10-Q filing | 30.0M shares outstanding |
30M | 0 |
| Feb 27, 2025 |
10-K filing | 29.3M shares outstanding |
29M | 0 |
| Nov 06, 2024 |
10-Q filing | 29.5M shares outstanding |
29M | 0 |
| Aug 07, 2024 |
10-Q filing | 29.2M shares outstanding |
29M | 0 |
| May 07, 2024 |
10-Q filing | 28.9M shares outstanding |
29M | 0 |
| Feb 29, 2024 |
10-K filing | 28.0M shares outstanding |
28M | 0 |
| Nov 09, 2023 |
10-Q filing | 28.1M shares outstanding |
28M | 0 |
| Aug 08, 2023 |
10-Q filing | 27.8M shares outstanding |
28M | 0 |
| May 09, 2023 |
10-Q filing | 27.6M shares outstanding |
28M | 0 |
| Mar 01, 2023 |
10-K filing | 27.4M shares outstanding |
27M | 0 |
| Nov 08, 2022 |
10-Q filing | 27.3M shares outstanding |
27M | 0 |
| Aug 24, 2022 |
S-3 filing: The company filed an S-3 form to register the offering of common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and units in one or more offerings and in any combination, with a total aggregate offering price not to exceed $300,000,000. |
27M | 0 |
| Aug 09, 2022 |
10-Q filing | 27.3M shares outstanding |
27M | 0 |
| May 06, 2022 |
10-Q filing | 27.3M shares outstanding |
27M | 0 |
| Mar 02, 2022 |
POS AM filing: The selling stockholder may from time to time offer and sell up to 3,019,360 shares of our common stock. |
27M | 0 |
| Mar 01, 2022 |
10-K filing | 26.8M shares outstanding |
27M | 0 |
| Nov 08, 2021 |
10-Q filing | 26.8M shares outstanding |
27M | 0 |
| Aug 09, 2021 |
10-Q filing | 26.7M shares outstanding |
27M | 0 |
| May 10, 2021 |
10-Q filing | 26.6M shares outstanding |
27M | 0 |
| Feb 26, 2021 |
10-K filing | 26.0M shares outstanding |
26M | 0 |
| Feb 18, 2021 |
8-K filing: The Company entered into an Investment Agreement to sell 2,250,000 shares of Series A Preferred Stock to Echelon Health SPV, LP at $100 per share for an aggregate purchase price of $225,000,000, subject to certain closing conditions. ($225.0M proceeds) |
26M | 0 |
| Jan 29, 2021 |
8-K filing: eHealth, Inc. entered into a binding term sheet with an affiliate of H.I.G. Capital, agreeing to sell 2,250,000 shares of newly designated 8% convertible preferred stock at $100 per share for an aggregate purchase price of $225,000,000. ($225.0M proceeds) |
26M | 0 |
| Nov 05, 2020 |
10-Q filing | 25.9M shares outstanding |
26M | 0 |
| Aug 06, 2020 |
10-Q filing | 26.4M shares outstanding |
26M | 0 |
| May 11, 2020 |
10-Q filing | 26.2M shares outstanding |
26M | 0 |
| Mar 05, 2020 |
8-K filing: eHealth Inc. issued and sold 1,800,000 shares of common stock in a public offering, with an additional 270,000 shares sold upon the exercise of an underwriter option. The offering is expected to close on March 6, 2020, with net proceeds of approximately $227.5 million. ($227.5M proceeds) |
19M | 0 |
| Mar 02, 2020 |
10-K filing | 19.4M shares outstanding |
19M | 0 |